Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:18-HETE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003050 AN005001 Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets (Part 1) Blood Human University of Vienna LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo LC-MS
ST001680 AN002738 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo